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To unravel the cytotoxic eﬀect of the recombinant CFP-10/ESAT-6 protein (rCFES) on WI-38 cells, an integrative analysis
approach, combining time-course microarray data and annotated pathway databases, was proposed with the emphasis on
identifying the potentially crucial pathways. The potentially crucial pathways were selected based on a composite criterion
characterizing the average signiﬁcance and topological properties of important genes. The analysis results suggested that the
regulatory eﬀect of rCFES was at least involved in cell proliferation, cell motility, cell survival, and metabolisms of WI-38 cells. The
survivability of WI-38 cells, in particular, was signiﬁcantly decreased to 62% with 12.5μM rCFES. Furthermore, the focal adhesion
pathway was identiﬁed as the potentially most-crucial pathway and 58 of 65 important genes in this pathway were downregulated
by rCFES treatment. Using qRT-PCR, we have conﬁrmed the changes in the expression levels of LAMA4, PIK3R3, BIRC3, and
NFKBIA, suggesting that these proteins may play an essential role in the cytotoxic process in the rCFES-treated WI-38 cells.
Copyright © 2009 Kun-Nan Tsai et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Mycobacterium tuberculosis is a global infectious disease that
has aﬀected one-third of the world population, killing 2-
3 million people and causing 7-8 million new infections
annually [1]. M. tuberculosis (MTB) is a major cause of
human tuberculosis. During the early stages of human
tuberculosis, MTB induces an immune response [2]a n d
subsequently leads to the development of lung granulomas
consisting of macrophages, T cells, B cells, and ﬁbroblasts
[3]. Recent researches reveal that ﬁbroblasts are not only
essential in secreting chemokine for modulating inﬂamma-
tory response to MTB infection and inﬂuencing the survival
of MTB within macrophages [4] but also involved in the
regulation of granuloma formation during MTB infection
[4, 5]. Despite the potentially vital role of ﬁbroblasts in
MTB infection, the detailed MTB-regulated mechanism
in ﬁbroblasts, especially its relationship to MTB secreted
protein, remains unknown.
Two secreted proteins CFP-10 and ESAT-6, produced by
theregionofdiﬀerence1(RD1)inMTB,havebeenidentiﬁed
to play important roles in the pathogenesis of tuberculosis
[6–8] in primary pulmonary infection. These two proteins
have also been shown to be virulence factors with cytotoxic
eﬀects on macrophages, lung epithelial cells, and dendritic
cells [8–10]. Individually, the cytotoxic eﬀect of ESAT-6
protein has been found to evoke apoptosis of macrophages,
dendritic cells, and ﬁbroblasts [11]. Recent report reveals
that CFP-10 and ESAT-6 choose a stable structure, forming
a 1 : 1 heterodimeric complex [12]—the CFP-10/ESAT-6
protein (CFES). It has been shown that CFES elicits immune
responseinthehostorganism[13,14].However,theroleand
function of CFES in ﬁbroblasts is not clear. Therefore, as our
ﬁrst attempt to unravel the eﬀect of CFES on ﬁbroblasts, an
integrative analysis approach combining biological resources
and bioinformatics was developed in this study.
Microarray is a biological resource, which has been
often used to analyze gene expression proﬁles in biological2 Journal of Biomedicine and Biotechnology
experiments. Most analysis tools for microarray data, for
example, SAM [15], LPE [16], Bayesian [17], and so forth,
have been designed mainly for identiﬁcation of important
genes. Other tools like GenMAPP [18], PharmGKB [19],
and KEGG [20] only show the positions of the genes
on a known pathway. Although some softwares such as
ArrayXpath [21] integrate the pathway resources and pro-
vide analysis and visualization tools for deciphering the
important genes and pathway structures, no notion of
chaining or aggregating regulatory eﬀect in a biological
process has been taken into account in identifying the
crucial pathways. To characterize the regulation mechanism
of recombinant CFP-10/ESAT-6 protein (rCFES) on WI-
38 cells taking account of the chaining or aggregating
regulatory eﬀect, an integrative analysis approach was pro-
posed in this study. By combining time-course microarray
data and annotated pathway databases, a new composite
score quantifying the average signiﬁcance and topological
properties of important genes in a pathway was proposed
to identify the potentially crucial pathways. Biologically, a
crucial pathway in this study is a pathway that is substantially
inﬂuenced by the rCFES-treatment, the consequence of
which is highly related to the observed response in the
rCFES-treated WI-38 cells, for example, the increased cell
deathrate.Nevertheless,sincethecrucialpathwayssuggested
by any computational analysis approach like the proposed
one require further experimental veriﬁcation, they are thus
considered as “potentially crucial pathways”. A pathway with
a better composite score was considered to be potentially
more crucial in an rCFES-treated WI-38 cell in the sense
that (i) the important genes in this pathway were more
signiﬁcantly expressed, (ii) this pathway contained a higher
percentage of important genes, and (iii) the important
genes in this pathway interacted more closely with one
another. Based on the composite scores, the pathways with
the best composite scores were suggested as the potentially
crucial pathways in an rCFES-treated WI-38 cell, which
may serve as the basis for further experimental studies
on unraveling the cytotoxic eﬀect of rCFES on WI-38
cells.
2.MaterialsandMethods
2.1. Cell Cultures. WI-38 cells were cultured in Mod-
iﬁed Eagle Medium (Gibco) containing 10% fetal calf
serum (FCS), 2mM L-glutamine, 1mM sodium pyruvate,
100μg/mL streptomycin, 0.025μg/mL amphotericin B, and
100U/mL penicillin at 37
◦Cw i t h5 %C O 2 .
2.2. Expression and Puriﬁcation of rCFES. The bacterial
vector pET29b-CFES was created by cloning CFP-10 and
ESAT-6 from the H37Rv strain of MTB and was transformed
into Escherichia coli BL21 (DE3). IPTG was used to express
abundant amounts of recombinant CFP-10/ESAT-6 protein
(rCFES). Next, wepuriﬁed recombinant rCFES using aﬃnity
chromatography with nickel ion characteristic and dialysis.
The Bio-Rad DC Protein Assay Kit was used to measure
rCFES concentrations. Thepurity of rCFES wascontrolledat
a level higher than 95% as assessed by densitometry of 12%
SDS-PAGE gels. In addition, MALTI-TOF mass spectroscopy
was used to conﬁrm that rCFES was composed of CFP-10
and ESAT-6. More detailed conﬁrmation analysis may be
found in Supplemental Data I (http://homepage.ntu.edu.tw/
∼d91548013/CFES supp data1.pdf).
2.3. Cell Survival Assay. WI-38 cells were seeded at 1.3 ×
104 cells per well in 96-well plates containing Modiﬁed Eagle
Medium with 10% FCS. The ﬁbroblasts were arrested at the
G0/G1 phase after treatment with serum-free medium for
24 hours, further treated with rCFES at diﬀerent concentra-
tions, including 0, 0.625, 1.25, 3.125, 6.25, 12.5, and 25μM,
and incubated for 48 hours. The cell viability was measured
with Cell Proliferation Assay Kit (Promega). The absorbance
was recorded at 490nm using a 96-well-plated reader. The
assay was performed in triplicate on control and rCFES-
treated WI-38 cells at diﬀerent concentrations.
2.4. Microarray Analysis. WI-38 cells were arrested at the
G0/G1 phase after treatment with serum-free medium for
24 hours, treated with rCFES (12.5μM), and incubated for
0, 3, 8, 16, 24, 32, 40, and 48 hours. Total RNA was extracted
with Trizol reagent, according to the manufacturer’sprotocol
(Invitrogen) and with RNeasy Mini Kit (Qiagen). RNA was
also extracted from nontreated WI-38 cells as control at the
sametimes.Inthisstudy,experimentsoncontrolandrCFES-
treated cells were performed in triplicate at each time point.
Puriﬁed RNA was quantiﬁed at OD260 with an ND-1000
spectrophotometer (Nanodrop) and qualitated with Agilent
Bioanalyzer 2100 (Agilent).
Total RNA was ampliﬁed with a Fluorescent Linear
Ampliﬁcation Kit (Agilent) and labelled with Cy3-CTP or
Cy5-CTP(CyDye,PerkinElmer).Next,cRNAwashybridized
onto human whole genome oligo microarrays (Agilent),
according to the manufacturer’s protocols. A total of 43931
probe sets on the arrays were analyzed. After washing and
drying by blowing with a nitrogen gun, microarrays were
scanned with an Agilent microarray scanner (Agilent) at
535nm for Cy3 and 625nm for Cy5. Feature Extraction
Software (Agilent) was used to analyze the scanned images
and to estimate diﬀerential gene expression by calculating
statisticalconﬁdences.Weselected41675probesetsbyrank-
consistency-ﬁltering using the LOWESS method.
2.5. Signiﬁcance Analysis of Gene Expression. The following
is screening conditions for selecting the matched genes at
every time point: rBGSubSignal >32, gBGSubSignal >32,
and absolute value log2 ratio >0. The unions of genes
passing this ﬁlter were used as the input data. Signiﬁcance
analysis of microarray (SAM) [15] was then performed to
identify important genes using the false discovery rate (FDR)
controlling procedures.
2.6. Pathway Topology Analysis. Pathway topology analysis
aimed to identify the potentially crucial pathways involved
in the biological process for WI-38 cells treated with rCFES.
The potentially crucial pathways were selected in two stepsJournal of Biomedicine and Biotechnology 3
based on a composite criterion characterizing multiple
clustering properties of important genes. In the ﬁrst step,
called pathway enrichment analysis, a set of pathways were
chosen as the candidates of the potentially crucial pathways,
each of which consisted of a signiﬁcant proportion of genes
that were important genes in the pathway. In the second
step, these candidates were ranked according to a scoring
system combining several descriptors that quantify the
average signiﬁcance and topological properties of important
genes.
More speciﬁcally, in the ﬁrst step, important genes were
mapped onto the human pathways constructed in the KEGG
databases using LocusLink IDs. Supposed that there were T
total genes with LocusLink IDs, out of which N genes were
m a p p e dt oap a t h w a y ,s a yp a t h w a yPj. Moreover, supposed
that there were t important genes in total, out of which k
importantgeneswereinvolvedinpathwayPj.Todetermineif
pathway Pj contained a signiﬁcant proportion of important
genes, hyper geometric statistic test was used with the null
hypothesis that k/t was not greater than N/T, given that N
and t are both greater than 0. The P-value for pathway Pj
was calculated as
p = 1 −
k 
i=0

t
i

T−t
N−i


T
N
 . (1)
While the P-value represented the signiﬁcance of path-
way Pj having a signiﬁcant proportion of genes that were
important genes, it also stood for the Type I error rate,
that is, the probability that k/t was mistakenly inferred
to be signiﬁcantly higher than N/T. Statistically, the more
pathways were tested, the greater probability it might have
to observe a false-positive result. With the hundreds of
pathways to be tested, to control the overall Type I error rate
ofmultipletesting,falsediscoveryrate(FDR)[22]c orr ection
was employed in this study.
The second step was to further rank the importance
of the candidates selected in the ﬁrst step based on the
average signiﬁcance and topological properties of impor-
tant genes. The average signiﬁcance quantiﬁed the overall
signiﬁcance of the important genes identiﬁed in pathway
Pj. Two descriptors were computed to represent the average
signiﬁcance. The ﬁrst one, denoted by Qs, was deﬁned as the
geometric mean of the q-values computed by SAM for the
important genes in pathway Pj.T h eg e o m e t r i cm e a ni n s t e a d
of arithmetic mean was adopted because the q-values of the
genes in a pathway may span several orders of magnitude.
If arithmetic mean is taken, the genes with large q-values,
even if they are minority in the pathway, may dominate the
mean value, yielding a misleading result. The second one,
denoted by Qps, was deﬁned as the geometric mean of the
cooccurrence signiﬁcances of all pairs of important genes
in pathway Pj. A pair of important genes was composed
of two directly connected important genes in the KEGG
pathway database and the cooccurrence signiﬁcance of a
pair of important genes was deﬁned as the product of
the q-values of these two genes. While Qs measured the
overall signiﬁcance due to individual important genes, Qps
placed more emphasis on the signiﬁcance characterizing the
cooccurrence of a pair of important genes. It was assumed
that a gene pair with two highly important genes would
be more valuable than that with two genes of moderate
signiﬁcance.
Two classes of topological properties of important genes
were quantiﬁed to represent the overall signiﬁcance of
pathway Pj in the underlying biological process. One was
density and the other was clustering. Density referred to the
average compactness of important genes in pathway Pj.T w o
density descriptors, named Qd and Qpd, were computed. Qd
was deﬁned as the ratio of the number of important genes
to the total number of genes in pathway Pj,w h e r e a sQpd
was deﬁned as the ratio of the number of pairs of important
genestothetotalnumberofgenepairsinthepathway.Agene
pair consisted of two directly connected genes in the KEGG
pathway database.
Clustering was performed based on the important genes
mapped onto the KEGG database and the connection
information among the mapped important genes provided
by the KEGG database. Clustering revealed how closely
the important genes were connected. A cluster was an
aggregation of connected important genes. Two types of
clustering, that is, directed clustering and undirected clus-
tering, were considered, which were characterized by two
pairs of topological descriptors. In a directed cluster, one
may traverse all important genes starting from at least one
gene, called root gene, following the upstream-downstream
relation between every pair of connected important genes.
On the other hand, in an undirected cluster, every link con-
necting two important genes deﬁned in the KEGG databases
was regarded as an undirected link. That is, one may traverse
from any gene in an undirected cluster to all the other
genes in the same cluster without considering the upstream-
downstream relation. More detailed descriptions for the
roles of the directed and undirected clusterings may be
found in Supplemental Data I (http://homepage.ntu.edu.tw/
∼d91548013/CFES supp data1.pdf).
The ﬁrst pair of topological descriptors, denoted as Ncd
and Qcd, stood for the number of important genes and
the geometric mean of the q-values computed by SAM for
the important genes, respectively, in the maximum directed
cluster of pathway Pj. If more than one maximum directed
cluster was identiﬁed in pathway Pj, the maximum directed
cluster with the smallest Qcd was chosen. The second pair of
topological descriptors, denoted as Ncu and Qcu,r e p r e s e n t e d
the number of important genes and the geometric mean
of the q-values of the important genes, respectively, in the
maximum undirected cluster of pathway Pj. Similarly, if
more than one maximum undirected cluster was identiﬁed
in pathway Pj, the maximum undirected cluster with the
smallest Qcu was chosen. For convenience, the clusters
quantiﬁed by the ﬁrst, and second pairs of topological
descriptors were termed as MD-cluster, and MUD-cluster,
respectively.
To determine the potentially crucial pathways, the can-
didate pathways selected in the ﬁrst step were ranked based
on a composite score, Rr, which was deﬁned as the sum
of the individual ranks of the descriptors for the average4 Journal of Biomedicine and Biotechnology
signiﬁcance and topological properties. More speciﬁcally,
Rr = Ra +Rd,w h e r e
Ra = rank(Sa(Qs))+ran k

Sa

Qps

+ran k(Sa(Qcd))+ran k(Sa(Qcu)),
Rd = rank(Sd(Qd))+ran k

Sd

Qpd

+ran k(Sd(Ncd))+ran k(Sd(Ncu)),
(2)
where Sa(X)a n dSd(Y) are two sorting functions that sort
X and Y in the ascending order and descending order,
respectively, and “rank” denotes the rank in the sorted
sequence. The smaller the composite score was, the more
likely a pathway was considered to be a potentially crucial
pathway.
2.7. QRT-PCR Analysis. To validate the microarray data,
real-time qRT-PCR using SYBR Green I Kit (Roche) was
performed to assess RNA expression level accuracy. A set
of important genes were selected for qRT-PCR assessment.
Some of them were from the highest-ranking potentially
crucial pathway based on the pathway topology analysis and
the others were the immediate downstream genes of the
highest-ranking potentially crucial pathway. The same RNA
samples as those isolated for microarrays at 3, 8, 16, 24, 32,
40, and 48 hours were used for RT-PCR. TATA box-binding
protein (TBP) was used as the internal control gene. It was
performed in triplicate for control and rCFES-treated WI-38
cells of the same time point.
3. Results andDiscussion
3.1. Cytotoxic Eﬀect of rCFES on WI-38 Cells. To understand
the eﬀect of recombinant CFP-10/ESAT-6 protein (rCFES)
treatment on the survival of human lung ﬁbroblasts, rCFES
was puriﬁed by aﬃnity chromatography. To ensure the
treatmentresponsewasduetorCFES,apurityofhigherthan
95% was achieved as determined by densitometric scanning
of the 12% SDS-PAGE (Figure 1). Then, WI-38 cells were
treatedwithdiﬀerentconcentrationsofrCFESandincubated
for 48 hours. Cell viability of WI-38 cells was determined
by MTS assay. It was found that the survival rate of WI-38
cells decreased and the decrement varied with the diﬀerent
concentrations of rCFES. For example, only 62% WI-38
cells survived after 12.5μM rCFES treatment (Figure 2),
which suggested that rCFES inﬂuenced cell survival and
consequently caused death in 48 hours. Based on these
evidences, we inferred that rCFES could induce WI-38 cell
death via cytotoxic process.
3.2. Identiﬁcation of Important Genes. To identify the impor-
tant genes involved in the rCFES-regulated mechanism of
WI-38 cells, the microarray data for 0, 3, 8, 16, 24, 32, 40,
and 48 hours were analyzed by SAM. Totally, 6542 important
genes were identiﬁed with the following parameters: data
type=oneclasstimecourse,timesummarymethod =signed
(kDa)
51.7
34.1
28.9
20.8
6.8
M 1 2
Figure 1: SDS-PAGE analysis of the puriﬁed rCFES. Lane M:
Protein marker; Lane 1: IPTG-induced cell lysate; Lane 2: puriﬁed
rCFES.
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Figure 2: Eﬀects of rCFES on WI-38 cell viability, in which the
bars indicated the survival rates of WI-38 cells treated with diﬀerent
concentrations of rCFES. The data are expressed as mean values (±
standard deviation) of three experiments.
area, Δ = 0.511 at time course, and false discovery rate =
4.74%. Out of these 6542 important genes, 2074 genes were
upregulated and 4468 genes were downregulated with rCFES
treatment.
3.3. Potentially Crucial Pathways in rCFES-Induced WI-38
Cells. To unravel the cytotoxic eﬀect of rCFES on WI-
38 cells, an integrative analysis approach was proposed
in this study with the emphasis on identiﬁcation of the
potentially crucial pathways. While the high-throughput
biological experiments, for example, microarray data, may
provide hundreds or thousands of important genes revealing
changes of expressions induced by rCFES, the information at
the gene level may be too overwhelming to extract the most
important regulatory eﬀects. Moreover, the analysis resultsJournal of Biomedicine and Biotechnology 5
are generallylack of the notion at the system level. To remedy
thesedeﬁciencies,theproposedintegrativeanalysisapproach
aimed at ﬁnding the pathways that played crucial roles in
rCFES-induced WI-38 cells.
We integrated the signiﬁcance of gene expressions and
topological distribution of important genes to account
for the regulatory eﬀects at the gene and system levels.
While important genes represented the regulatory eﬀects of
rCFES on individual genes, topological distribution of the
important genes bore the notion of chaining or aggregating
regulatory eﬀects on genetic subnetworks of WI-38 cells.
Suppose that there were two pathways containing the same
number of important genes with similar signiﬁcance, if the
important genes distributed sporadically in one pathway and
were highly connected in the other, the proposed approach
preferred the latter to the former. This was because a
cluster of connected genes implied a chaining or aggregating
regulatory eﬀect of rCFES on WI-38 cells, which deserved a
further investigation.
With a control of the false discovery rate at 5%, 23
pathways as listed in Table 1 were identiﬁed to be the
candidates of potentially crucial pathways in rCFES-induced
WI-38 cells based on the hyper geometric statistic test.
Ranking these 23 pathways according to the composite score,
Rr, the second step of pathway topology analysis further
suggested that the focal adhesion pathway is the potentially
most crucial pathway in rCFES-induced WI-38 cells. Other
than the focal adhesion pathway, the proposed integrative
analysis approach also suggested that several metabolism
pathways of WI-38 cells (as listed in Table 1) might play
crucial role in the response to the treatment of rCFES.
Whilefurtherinvestigationwouldberequiredtovalidatethis
ﬁnding, it was partially supported by some previous studies,
in which antibacterial genes of the immune cells infected
with MTB were found to be involved in metabolism [23, 24].
To characterize the functional signiﬁcance of the focal
adhesion pathway, the topological and functional properties
of the important genes involved in this pathway were
elaborately analyzed. With the false discovery rate of 4.74%,
65 important genes, including 7 upregulated genes and
58 downregulated genes (Table 2), were selected by SAM
for the focal adhesion pathway annotated by the KEGG
database. The root gene of the MD-cluster identiﬁed by
the pathway topology analysis was ITGB1. The functional
interpretations of these 65 important genes were annotated
by GOstat [25] using biological process terms at P-value
< 2 ∗ 10
−20 and numbers of gene >16, the results of which
were shown in Figure 3. The GO terms that best described
the functional disorders associated with these 65 important
genes were developmental process, cell motility, localization
of cell, biological adhesion, and cell adhesion. Most gene
functions of 65 important genes were downregulated by
cytotoxic eﬀect of rCFES. Combining the analysis results of
gene ontology, pathway topology analysis and annotation
of KEGG database, overall speaking, the biological process
of WI-38 cells treated with rCFES involved such functions
as cell proliferation, cell motility, cell survival, amino acid
metabolism, and so on. In particular, many of them were
related to cell survival.
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Figure 3: Functional analysis of the 65 important genes in the
focal adhesion pathway using GOstat, in which ﬁve GO terms were
identiﬁed to best describe the functional disorders associated with
these 65 important genes, including developmental process, cell
motility, localization of cell, biological adhesion, and cell adhesion.
To check if the proposed approach is also applicable
to other microarray data, the same approach is used to
analyzeasetofpubliclyavailablehumanneutrophilmicroar-
ray data. The analysis results may be found in Supple-
mental Data II (http://homepage.ntu.edu.tw/∼d91548013/
CFES supp data2.pdf).
3.4. Validation of Important Genes by qRT-PCR. Twenty-
three pathways were identiﬁed as the potentially crucial
pathways in rCFES-induced WI-38 cells and the focal
adhesion pathway was considered as the most crucial one.
These ﬁndings were based on the correctness of the gene
expressions revealed by microarrays. To further corroborate
the basis of the pathway topology analysis, the gene expres-
sions of 5 important genes involved in the focal adhesion
pathway were validated by qRT-PCR. These 5 genes were
LAMA4,ITGB1,PIK3R3,BIRC3,andNFKBIA.Accordingto
gene annotations from KEGG databases, ITGB1 was the root
geneofthefocaladhesionpathway.LAMA4wasanupstream
gene of ITGB1. PIK3R3 was a downstream gene of ITGB1.
BIRC3 and NFKBIA were the downstream genes of PIK3R3.
LAMA4 was also related to the ECM receptor interaction
pathway. BIRC3 and NFKBIA were directly involved in the
apoptosis pathway.
Figure 4providedthefoldchangesmeasuredbymicroar-
ray data and qRT-PCR for these 5 important genes at
each time point. The qRT-PCR results were generally in
congruence with the microarray data for LAMA4, PIK3R3,
BIRC3, and NFKBIA in terms of up- or downregulation
(Pearson correlations: 0.66∼0.82). More speciﬁcally, the ﬁrst
two genes, LAMA4 and PIK3R3, were downregulated by
rCFES treatment and the last two genes, BIRC3, and NFK-
BIA, were upregulated by rCFES treatment. Nevertheless,
the microarray data of ITGB1 was not in agreement with6 Journal of Biomedicine and Biotechnology
Table 1: The values of the descriptors constituting the composite score, Rr, and the selected pathways sorted in the ascending order of Rr
derived by the pathway topology analysis.
Pathway Density Average signiﬁcance MD-Cluster MUD-Cluster Composite
score
Entry Name KQ d Qpd Qs Qps Ncd Qcd Ncu Qcu Rr
hsa04510 Focal adhesion 65 0.3351 0.2697 0.00130 0.00000039 11 0.00177 13 0.00200 46
hsa00450 Selenoamino acid
metabolism
14 0.4118 0.5833 0.00119 0.00000365 6 0.00195 7 0.00221 49
hsa00230 Purine metabolism 54 0.3506 0.4230 0.00501 0.00002726 44 0.00566 51 0.00523 59
hsa00271 Methionine
metabolism
11 0.6875 0.3158 0.00239 0.00001452 4 0.00044 7 0.00239 59.5
hsa00260 Glycine, serine and
threonine metabolism
16 0.3556 0.1391 0.00168 0.00000594 6 0.00153 8 0.00082 61.5
hsa00330 Arginine and proline
metabolism
21 0.3448 0.2075 0.00207 0.00001056 10 0.00223 14 0.00388 64
hsa04512 ECM-receptor
interaction
31 0.3563 0.0909 0.00076 0.00000023 2 0.00010 5 0.00058 71.5
hsa00280 Valine, leucine and
isoleucine degradation
19 0.3519 0.3913 0.00636 0.00002807 10 0.00657 14 0.00760 72
hsa00310 Lysine degradation 18 0.3462 0.4231 0.00453 0.00000841 5 0.01567 5 0.00035 82
hsa00100 Biosynthesis of steroids 8 0.4444 0.3902 0.00754 0.00006827 9 0.00769 9 0.00769 87
hsa04670
Leukocyte
transendothelial
migration
31 0.2650 0.0656 0.00135 0.00000028 2 0.00007 3 0.00030 87.5
hsa04910 Insulin signaling
pathway
41 0.3037 0.1647 0.00713 0.00001028 8 0.00535 9 0.00583 89.5
hsa00380 Tryptophan
metabolism
30 0.3488 0.2289 0.00850 0.00006979 6 0.00455 7 0.00543 100
hsa00130 Ubiquinone
biosynthesis
7 0.4667 0.2500 0.00672 0.00003048 2 0.00552 2 0.00552 100
hsa00564 Glycerophospholipid
metabolism
19 0.2468 0.2464 0.00692 0.00005076 7 0.00742 10 0.00786 103.5
hsa00020 Citrate cycle (TCA
cycle)
14 0.4643 0.1121 0.00959 0.00006191 7 0.00758 7 0.00758 105
hsa00650 Butanoate metabolism 20 0.4545 0.2326 0.00713 0.00007358 6 0.00977 6 0.00977 108
hsa04514 Cell adhesion
molecules (CAMs)
36 0.2727 0.1565 0.00305 0.00009319 2 0.00195 2 0.00195 112
hsa05120
Epithelial cell signaling
in Helicobacter pylori
infection
13 0.2826 0.1200 0.00513 0.00012724 3 0.00875 3 0.00875 135.5
hsa00500 Starch and sucrose
metabolism
23 0.2949 0.1250 0.00955 0.00018004 5 0.01366 6 0.01538 141.5
hsa00625 Tetrachloroethene
degradation
4 0.4444 0.1250 0.02087 0.00043538 2 0.02087 2 0.02087 149
hsa00970 Aminoacyl-tRNA
biosynthesis
12 0.3750 0.0476 0.00654 0.00077841 2 0.02790 2 0.02790 154
hsa00040
Pentose and
glucuronate
interconversions
6 0.2500 0.0588 0.00915 0.00050551 2 0.02248 2 0.02248 171
the readings of qRT-PCR (Pearson correlations <0), though
ITGB1 was identiﬁed as the root gene in the focal adhesion
pathway. One reasonable explanation for this inconsistency
was that the microarray data were inherently noisy, and there
was a false discovery rate associated with the microarray data
analysis for ITGB1.
Among the conﬁrmed genes, the downregulation of
LAMA4 would aﬀect cell survival via laminin-integrin inter-
action [26, 27] and the downregulation of PI3K would aﬀect
the survival signal transduction via an integrin/PI3K/Akt
pathway [28]. Furthermore, the upregulation of baculoviral
IAP repeat-containing 3 (BIRC3), known as an inhibitor ofJournal of Biomedicine and Biotechnology 7
Table 2: Gene names, gene descriptions, and signiﬁcance analysis results of mapped genes in focal adhesion pathway obtained via SAM
analysis, where “[]” showed upregulated (+) or downregulated (−) by rCFES treatment at q-value <5%.
No. Gene Gene Description q-value
1 SHC3 SHC transforming protein 3 0.0000 [+]
2 ACTN2 Actinin, alpha 2 0.0068 [+]
3 BIRC3 Baculoviral IAP repeat-containing 3 0.0211 [+]
4 SPP1 Secreted phosphoprotein 1 0.0211 [+]
5 AF086032 Protein phosphatase 1, regulatory (inhibitor) subunit 12A 0.0278 [+]
6 KDR Kinase insert domain receptor 0.0278 [+]
7 DDI1 DDI1, DNA-damage inducible 1,homolog 1 (S. cerevisiae) 0.0278 [+]
8 ACTB Actin, beta 0.0000 [−]
9 FLNA Filamin A, alpha (actin binding protein 280) 0.0000 [−]
10 ACTG1 Actin, gamma 1 0.0000 [−]
11 CAV1 Caveolin 1, caveolae protein, 22kDa 0.0000 [−]
12 ITGB1 Integrin, beta 1 0.0000 [−]
13 ITGA6 Integrin, alpha 6 0.0000 [−]
14 COL1A2 Collagen, type I, alpha 2 0.0000 [−]
15 CAPN2 Calpain 2, (m/II) large subunit 0.0000 [−]
16 AKT1 V-akt murine thymoma viral oncogene homolog 1 0.0010 [−]
17 TNXB Tenascin XB 0.0010 [−]
18 ITGA5 Integrin, alpha 5 (ﬁbronectin receptor, alpha polypeptide) 0.0010 [−]
19 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 0.0014 [−]
20 ITGA8 Integrin, alpha 8 0.0014 [−]
21 ITGA4 Integrin, alpha 4 0.0014 [−]
22 PIK3R3 Phosphoinositide-3-kinase,regulatory subunit 3 (p55, gamma) 0.0014 [−]
23 FN1 Fibronectin 1 0.0014 [−]
24 LAMA4 Laminin, alpha 4 0.0016 [−]
25 THBS1 Thrombospondin 1 0.0016 [−]
26 IGF1R Insulin-like growth factor 1 receptor 0.0016 [−]
27 COL1A1 Collagen, type I, alpha 1 0.0016 [−]
28 CCND1 Cyclin D1 0.0016 [−]
29 MET Met proto-oncogene (hepatocyte growth factor receptor) 0.0016 [−]
30 ACTN4 Actinin, alpha 4 0.0019 [−]
31 AK025363 Parvin, alpha 0.0019 [−]
32 AKT2 V-akt murine thymoma viral oncogene homolog 2 0.0019 [−]
33 CAV2 Caveolin 2 0.0027 [−]
34 VCL Vinculin 0.0027 [−]
35 ZYX Zyxin 0.0027 [−]
36 TNC Tenascin C (hexabrachion) 0.0027 [−]
37 ACTN3 Actinin, alpha 3 0.0028 [−]
38 VASP Vasodilator-stimulated phosphoprotein 0.0028 [−]
39 COL5A1 Collagen, type V, alpha 1 0.0028 [−]
40 VEGFC Vascular endothelial growth factor C 0.0039 [−]
41 FAK Focal adhesion kinase 0.0047 [−]
42 PARVB Parvin, beta 0.0047 [−]
43 COL4A6 Collagen, type IV, alpha 6 0.0047 [−]
44 LAMA5 Laminin, alpha 5 0.0068 [−]
45 MAPK1 Mitogen-activated protein kinase 1 0.0088 [−]
46 AK025363 Parvin, alpha 0.0019 [−]
47 THBS4 Thrombospondin 4 0.0116 [−]
48 ERBB2 V-erb-b2 erythroblastic leukemiaviral oncogene homolog 2 0.0157 [−]
49 AF207599 Homo sapiens pRb-interacting protein RbBP-36 mRNA 0.0157 [−]
50 DOCK1 Dedicator of cytokinesis 1 0.0157 [−]
51 COL5A2 Collagen, type V, alpha 2 0.0211 [−]8 Journal of Biomedicine and Biotechnology
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Figure 4: Validation of microarray data by qRT-PCR analysis for 5 genes: (a) LAMA4, (b) ITGB1, (c) PIK3R3, (d) BIRC3, and (e) NFKBIA.
The data are expressed as mean values (± standard deviation) of three experiments.Journal of Biomedicine and Biotechnology 9
Table 2: Continued.
No. Gene Gene Description q-value
52 PIK3R5 Phosphoinositide-3-kinase, regulatory subunit 5, p101 0.0211 [−]
53 ITGAV Integrin, alpha V 0.0211 [−]
54 LAMA2 Laminin, alpha 2 0.0278 [−]
55 ARHGAP5 Rho GTPase activating protein 5 0.0278 [−]
56 VAV2 Vav 2 oncogene 0.0278 [−]
57 CAV3 Caveolin 3 0.0278 [−]
58 BCAR1 Breast cancer anti-estrogen resistance 1 0.0369 [−]
59 EGFR Epidermal growth factor receptor 0.0369 [−]
60 MAPK9 Mitogen-activated protein kinase 9 0.0369 [−]
61 AA599881 Platelet-derived growth factor receptor, alpha polypeptide 0.0474 [−]
62 THBS1 Thrombospondin 1 0.0016 [−]
63 GRB2 Growth factor receptor-bound protein 2 0.0474 [−]
64 LAMA3 Laminin, alpha 3 0.0474 [−]
65 CRKL V-crk sarcoma virus CT10 oncogene homolog (avian)-like 0.0474 [−]
[26, 27] LAMA4
Cell death
Integrin
PI3K
BIRC3
CASP
rCFES 
NFKB 
NFKBIA 
NFKB 
NFKBIA 
[29]
[30-32]
Cell survival
[28]
αβ
Figure 5: Inferred model for the rCFES-regulated focal adhesion
pathway in WI-38 cells. LAMA4, PIK3R3, BIRC3, and NFKBIA
identiﬁed in this study were included in the rCFES-regulated
model in WI-38 cells. Upregulated genes were marked by “↑”a n d
downregulated genes by “⊥”. Dotted arrows were links requiring
further conﬁrmation and the numbers in “[]” were the supportive
previous works listed in the reference.
caspase family [29], would inhibit the activation of caspase
genes and the upregulation of NFKBIA would induce cell
apoptosis via interfering with NF-κBa c t i v a t i o n[ 30–32].
These results supported that rCFES could inﬂuence WI-
38 cell survivability via the regulation of focal adhesion
pathway at least. Based on these results, a working model was
inferred for the rCFES-regulated pathway in WI-38 cells in
Figure 5. Although this model needed further veriﬁcation, it
wasbelieved that these results willaid the investigation of the
CFES-regulated mechanism in human lung ﬁbroblasts.
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